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Cauda Equina Syndrome (CES) is an emergency condition that requires acute intervention
and can lead to permanent neurological deficit in working age adults. A Core Outcome Set
(COS) is the minimum set of outcomes that should be reported by a research study within a
specific disease area. There is significant heterogeneity in outcome reporting for CES,
which does not allow data synthesis between studies. The hypothesis is that a COS for CES
can be developed for future research studies using patients and healthcare professionals
(HCPs) as key stakeholders.
Methods and findings
Qualitative semi-structured interviews with CES patients were audio-recorded, transcribed
and analysed using NVivo to identify the outcomes of importance. These were combined
with the outcomes obtained from a published systematic literature review of CES patients.
The outcomes were grouped into a list of 37, for rating through two rounds of an international
Delphi survey according to pre-set criteria. The Delphi survey had an overall response rate
of 63% and included 172 participants (104 patients, 68 HCPs) from 14 countries who com-
pleted both rounds. Thirteen outcomes reached consensus at the end of the Delphi survey
and there was no attrition bias detected. The results were discussed at an international con-
sensus meeting attended by 34 key stakeholders (16 patients and 18 HCPs) from 8 coun-
tries. A further three outcomes were agreed to be included. There was no selection bias
detected at the consensus meeting. There are 16 outcomes in total in the CESCOS.
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Discussion
This is the first study in the literature that has determined the core outcomes in CES using a
transparent international consensus process involving healthcare professionals and CES
patients as key stakeholders. This COS is recommended as the most important outcomes
to be reported in any research study investigating CES outcomes and will allow evidence
synthesis in CES.
Introduction
Cauda Equina Syndrome (CES) is an emergency neurological condition that requires acute
intervention[1] and can cause significant neurological deficit including bladder, bowel, sexual
dysfunction and lower limb paralysis[2, 3]. The incidence of CES is 2 per 100,000 and is an
indication for emergency decompression surgery [4–6]. Inadequate management and poor
outcomes in CES may result in a high medico-legal burden[7]. CES is commonly categorised
into CES incomplete (CESI) and the more severe presentation of CES complete with urinary
retention (CESR)[5]. There is little in the literature regarding long term prognosis[8] and a
review of studies evaluating treatments for CES demonstrated heterogeneity in the outcome
domains measured [9]. In addition, the outcomes reported in the literature have not been
independently validated as important by key stakeholders. A Core Outcome Set (COS) is “an
agreed, standardised set of outcomes to be measured and reported, as a minimum, in all trials
for that particular health area”[10]. The concept of a COS was developed to standardise out-
comes across all relevant trials to allow comparisons of the results of different trials in a given
condition [11].
Objectives
This paper reports the consensus process which was undertaken with key stakeholders
(patients and healthcare professionals [HCPs]) to achieve the Cauda Equina Syndrome Core
Outcome Set (CESCOS). A systematic literature review and qualitative interviews were con-
ducted to identify a complete list of outcomes. These outcomes populated a two-round Delphi
survey, which participants completed and reviewed at a consensus meeting. Key stakeholders
identified the most important outcomes but the group did not intend to validate how to mea-
sure these outcomes in this study. This study is reported in accordance with the Core Outcome
Set-STAndards for Reporting (COS-STAR)[12] guidelines.
Scope
The health condition included all severities of CES. The population involved are adults with
CES over the age of 18 years. The intervention was medical and surgical management of CES
and the setting where the COS is to be applied is for any CES related research study.
Methods
Protocol/ Registry entry
The CESCOS is officially registered on the Core Outcome Measures in Effectiveness Trials
(COMET) database as study 824 (http://www.comet-initiative.org/studies/details/824). Details
regarding the methods are described in further detail in the protocol[13].
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Participants
Participants for the CESCOS Delphi survey were recruited from two key stakeholder groups:
patients with CES and HCPs who manage CES patients. All were adults aged over 18 years and
able to independently complete an online questionnaire in English. Participants were recruited
from a database at the local site, through snowball sampling [14] of known contacts and
through international and national HCP and patient organisations.
Information sources
A published systematic literature review (SLR) [9] identified all the outcomes documented in
studies since 1990 involving patients who had undergone surgery for CES. The outcomes from
the SLR were combined with the outcomes identified from the qualitative interviews to form
those initially rated on within the Delphi Survey. These qualitative interviews had been con-
ducted by NS with 22 patients treated at The Walton Centre between 2007 and 2016 for CES.
A sampling frame was applied to ensure patients with a range of CES severities (CESI or
CESR) and different times since the operation were interviewed. Semi-structured interviews
were conducted with a topic guide (S1 File) and involved patients’ describing their experience
of CES in a chronological manner to ascertain the relevant outcomes and the lived experience
of the condition. Interviews were audio recorded, transcribed and with the assistance of
NVivo (version 10), were coded using an inductive approach to identify outcomes. NS led the
analysis process and was supported by AN.
The SLR produced 737 verbatim outcome terms and the qualitative interviews identified
260. The qualitative interviews highlighted 43 verbatim outcome terms not identified by the
literature review, which were more concerned with life impact. There was a total of 997 verba-
tim outcome terms, which was condensed by the study team to 37 outcomes. These were cate-
gorised into five higher order categories as per the taxonomy recommended by COMET
(Clinical Outcomes, Life Impact, Resources Use, Death and Adverse Events) [15].
The process of reducing the “long list” to a “short list” of outcomes was reviewed by the
study team including patient research partners for face validity, understanding and acceptabil-
ity and modified according to feedback. For example, regarding low back pain there were 53
verbatim outcome terms from the SLR (n = 31) and the qualitative interviews (n = 22) but
these were all summarised to one outcome of low back pain. In addition, the terminology and
explanations of the outcomes were decided using the language from the patient interviews and
refined through a series of cognitive “think aloud” interviews conducted with HCPs and
patient representatives [16, 17].
Consensus process
Delphi survey. The “modified” Delphi method [18] was used with outcomes derived from
the SLR and interviews. Additional outcomes were suggested in round 1 by participants. Demo-
graphic details were collected on the registration page. The Delphi survey was anonymised and
only participants who responded to the first round of the Delphi were invited to participate in
the second round. Data was collected over a 4-week period for each Delphi round. The setup
and running of the survey were managed by using the DelphiManager software [19].
Consensus meeting. All participants needed to complete both rounds of the Delphi survey
to be eligible to attend the consensus meeting. A sampling frame was used to achieve a varied
sample of participants and representation from key stakeholder organisations. The meeting was
chaired by a trained non-clinical independent facilitator (SB) not on the study team. Forty par-
ticipants (20 patients and 20 HCPs) were invited to the consensus meeting: fifteen participants
in each group were from the UK and five in each group were from outside the UK.
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Outcome scoring
Delphi survey. Participants were asked to rate each outcome using a 9-point Likert scale (7
to 9 indicating critical importance, 4 to 6 representing outcomes that are important but not crit-
ical, 1 to 3 are deemed to be of limited importance). All outcomes were retained for voting in
the second round and presented with their anonymised first round scores from the patient and
HCP groups. Participants could decide to keep or change their original answers on second
thoughts. Attrition bias was assessed by comparing the average scores of participants who com-
pleted both rounds to the average score of the participants who only completed round one.
Consensus meeting. The main discussion at the consensus meeting considered the out-
comes with “No consensus” in the Delphi survey (Table 1). Participants at the meeting voted
on these outcomes anonymously using the TurningPoint system and handsets (Turning Tech-
nologies, Youngstown, OH, USA).
Consensus definition
We have adopted the “70/15” consensus definition in the protocol, which was used successfully
in other COS studies [20, 21] for inclusion of an outcome in the COS. However, it was partially
revised for “consensus out” due to the study team’s experience from other studies where out-
comes were rarely voted 1–3 not important and reach criteria for exclusion after the Delphi
survey[21]. This revision was done without reference to the identity of the outcomes. As a
result, the final definitions of consensus that were used are in Table 1. The same criteria were
used for the consensus meeting. All outcomes in the “consensus out” or “no consensus” cate-
gory after voting in the consensus meeting were not included in the COS. Feedback forms
were distributed and collected at the end of the meeting.
Ethics
Research Ethics Committee (REC) and Health Research Authority (HRA) approval was
obtained on December 2016 for the qualitative interviews by South Central- Hampshire A
Research Ethics Committee (REC reference 16/SC/0587). REC and HRA approval was
obtained on March 2018 for the Delphi process and consensus meeting by North West-
Greater Manchester Central Research Ethics Committee (REC reference 18/NW/0022).
Results
Protocol deviations
As mentioned before, the definition for an outcome not to be included (termed “consensus
out” in Table 1) was changed for the Delphi survey with agreement from the study team.
There were no other deviations from the protocol.




IN Consensus that an outcome should be
included in the core outcome set
70% or more participants scoring as 7 to 9 AND
<15% participants scoring as 1 to 3 in both the
patient and HCP groups
OUT Consensus that an outcome should
not be included in the core outcome
set
�50% of participants scoring as 7 to 9 in both the
patient and HCP groups
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Participants
Delphi survey. HCP and patient organisations who circulated the Delphi survey amongst
their membership are listed in the S1 Table. Round one was completed by 272 participants (189
patients, 83 HCPs). Both rounds were completed by 172 participants. Sixty percent were patients
(104) and 40% were HCPs (68). The overall response rate was 63% (55% for patients and 82%
for HCPs). The patient (Table 2) and HCP demographics (Table 3) are available below.
Consensus meeting. Thirty-four participants attended the consensus meeting (16 patients
and 18 HCPs). Twenty-five participants were from the UK and 9 were international. There
was international patient and healthcare representation from CES charity organisations and




























Employed full time 30 (29)
part time 10 (10)
Self employed 9 (9)
Unemployed 6 (6)
Unable to work 29 (28)
Homemaker 5 (5)
Retired 14 (13)
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HCP spine and rehabilitation organisations. The consensus meeting was chaired by a non-
clinical researcher (SB) independent to the study team with expertise in core outcome set
methodology.
Of the 18 HCPs at the consensus meeting, 10 were surgeons involved in acute CES manage-
ment and 8 were doctors and allied HCPs involved in the longer-term care and rehabilitation
of CES patients. In the patient group, there was an equal spread of patients in the years since
diagnosis of CES (<2: 5,�2<5: 4,�5<10: 6 and�10: 1).
When comparing average round two Delphi scores between participants who attended the
consensus meeting (patients mean 7 SD 1: HCPs mean 7 SD 0.7) to those participants who did
not attend the consensus meeting (patients mean 7 SD 0.85: HCPs 7 mean SD 1), there was no
participation bias.











Spinal Cord Injury 4 (6)
Spinal nurse 3 (4)
Physiotherapist 2 (3)
Psychologist 2 (3)















Czech Republic 1 (1)
USA 1 (1)
Brazil 1 (1)
New Zealand 1 (1)
Malaysia 1 (1)
https://doi.org/10.1371/journal.pone.0225907.t003
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Outcomes
Delphi survey. The list of the outcomes and agreed terminology with explanations used in
the Delphi survey are available in S2 Table. There was a total of 37 outcomes. Sixty-five additional
outcomes were suggested at the end of round 1 but only one outcome of “pain from abnormal
sensation or non-painful stimulus” was deemed appropriate to be included for round 2. The
other 64 suggestions were not included as 33 (52%) were not an outcome, 30 (47%) were covered
by other outcomes already on the Delphi survey and 1 (1%) suggestion was not due to CES.
Table 4 shows the percentage of participants who had voted 7 to 9 (critically important) for
each outcome at the end of rounds 1 and 2 of the Delphi survey. According to the pre-specified
scoring criteria (Table 1), 13 outcomes were included as “consensus in,” (green), 6 were “con-
sensus out” (blue) and 19 had “no consensus” at the end of both rounds. During the entry of
the outcome “pain from abnormal sensation or non-painful stimulus” for rating in round two
the “sensation in genitals” outcome was accidently deleted. Both these outcomes achieved
“consensus in” in the one round they were rated in so it was agreed by the study team to
include them in the list of “consensus in” outcomes.
In green are the outcomes that were included and blue were the outcomes excluded. X
denotes that an outcome has not been voted in the round.
There were 499 score changes in total in round 2. Patients made 326 (65%) score changes
and 173 (35%) were from HCPs. Most patients made score change based on personal reflection
(71%) whereas most HCPs (58%) had made the score changes based on stakeholder feedback.
The mean round 1 scores for patients (mean 7 SD 1.02) and HCPs (mean 6 SD 0.87) were not
different compared to the participants that completed both rounds for patients (mean 7 SD
0.93) and HCPs (mean 6 SD 0.87). This suggests that there was no attrition bias.
Consensus meeting. Table 5 shows the percentage of participants that voted 1–3, 4–6 and
7–9 for the “No consensus” outcomes in the consensus meeting. Three further outcomes were
included in the COS after voting in the consensus meeting; sensation of bladder fullness, low
mood and depression and social functioning.
The outcome that was re-voted on in the consensus meeting was low mood and depression.
The HCPs incorrectly assumed that since the outcome of global quality of life was in the COS
then low mood and depression would be automatically included in this outcome. The facilita-
tor highlighted that all quality of life measurements would not measure the same outcomes
and if participants wanted an outcome related to quality of life to be included they had to vote
it in. After adequate discussion, a re-vote was agreed by the study team, which resulted in the
outcome of low mood and depression being included. The outcome of death was deemed to be
already covered by the outcome of complications and the study team agreed to include this in
the definition of complications hence it was not voted on.
Foot drop, back pain and need for further intervention were voted as critically important
by patients but not by HCPs. Low back pain was not voted critically important by HCPs as
they felt it was due to several different causes so to ascribe it to CES would be incorrect. With
regards to foot drop this was not included as HCPs and some patients felt the outcome of
mobility and walking would encompass the effects experienced by foot drop. HCPs felt the
need for further intervention was already included within the outcome of complications. They
also felt further procedures related to the management of CES would say little regarding the
effectiveness of the initial intervention for CES.
The “no consensus” outcomes which were critically important by<70% of participants
from both stakeholder groups in the Delphi survey were agreed by the consensus meeting par-
ticipants to not be voted on and to accept the results of the Delphi; Sexual desire, constipation,
sensation in the legs, urinary urgency and abdominal pain. Fatigue although in this category
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was requested by the patient stakeholder group to be voted on again. Other outcomes already
included in the COS were contributory to fatigue such as mobility and walking, ability to do
daily activities and leg muscle strength and this was cited as a reason by a HCP and patient as
not choosing it critically important. It did not reach the criteria for inclusion in the COS.
The feedback for the consensus meeting was completed by 13 out of 16 patients (81%) and
16 out of 18 HCPs (89%). From the completed responses, 100% agreed that the meeting pro-
duced a fair result and they were comfortable communicating their views.
Table 4. Percentage of patients and HCPs scoring 7–9 (critical) for an outcome in rounds 1 and 2.
Outcome Patients (n = 189) R1 HCPs
(n = 83) R1
Patients
(n = 104) R2
HCPs (n = 68)
R2
Urinary retention 74 93 80 97
Sensation of bladder fullness 69 61 74 63
Incontinence of Urine 76 91 84 100
Urinary urgency 57 30 55 36
Urinary frequency 48 27 43 31
Constipation 67 25 66 31
Faecal Incontinence 80 94 89 99
Abdominal distention 49 18 42 12
Abdominal pain 54 23 52 24
Anal tone 63 57 76 69
Physical ability to have sexual intercourse 80 81 84 92
Leg muscle strength 71 67 80 72
Foot drop 64 60 76 60
Reflexes 51 11 44 3
Sensation in leg(s) 66 40 63 32
Pain from abnormal sensation or non-painful stimulus X X 85 81
Genital Sensation 82 72 X X
Perineal sensation 74 65 75 73
Lower back pain 83 29 83 35
Pain in leg and/or feet 82 48 83 53
Back stiffness 53 10 47 6
Leg stiffness 48 11 48 7
Fatigue 56 16 56 15
Non-specific pain 48 8 36 6
Global Quality of Life 85 80 90 75
Occupation/ Role functioning 72 81 85 88
Social functioning 62 70 66 73
Ability to do Daily activities (Physical functioning) 81 80 89 90
Mobility and Walking (Physical functioning) 86 82 91 88
Difficulty with body posture (Physical functioning) 60 52 70 50
Sexual desire (Emotional functioning) 64 64 65 65
Anxiety (Emotional functioning) 69 51 74 49
Isolation (Emotional functioning) 72 56 74 59
Low Mood and Depression (Emotional functioning) 75 58 78 63
Hospital resources 74 46 83 51
Need for further intervention 84 51 89 53
Death 54 59 66 72
Complications 78 65 82 72
https://doi.org/10.1371/journal.pone.0225907.t004
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The core outcome set
The final COS is listed in Table 6. There are 16 outcomes in total categorised under autonomic
function, non-autonomic function and quality of life.
Overview
The SLR (737) and qualitative interviews (260) identified 997 verbatim outcome terms. This
was then prioritised through a Delphi survey with 37 outcomes in total. An additional outcome
was added in the second round creating 38 outcomes. At the end of the Delphi survey 13 out-
comes were included in the COS. This was agreed at the consensus meeting and 3 extra out-
comes were included to the COS creating a total of 16 outcomes (Fig 1).
Table 5. Percentages of patients and HCPs who voted 1–3 (not important), 4–6 (important but not critical), 7–9
(critical) for the “no consensus” outcomes at the consensus meeting.
Outcome Patient (n = 16) (%) HCP (n = 18) (%)
1–3 4–6 7–9 1–3 4–6 7–9
Anal tone 19 62 19 29 62 12
Sensation of bladder fullness 0 12 87 0 23 78
Foot drop 0 12 88 0 50 50
Pain in leg or feet 0 44 56 6 61 34
Back Pain 0 12 88 12 29 62
Low mood and depression 0 0 100 0 17 83
Social functioning 0 12 88 0 28 72
Isolation 0 69 31 0 72 28
Anxiety 0 31 69 0 50 50
Difficulty of body posture 0 50 51 0 83 17
Need for further intervention 0 19 82 0 44 56
Hospital resources 6 82 13 17 72 11
Fatigue 0 33 67 0 78 22
https://doi.org/10.1371/journal.pone.0225907.t005
Table 6. The 16 outcomes that constitute the Cauda Equina Syndrome core outcome set.
CES Core Outcome Set
Autonomic function Bladder function Incontinence of Urine
Urinary retention
Sensation of bladder fullness
Bowel function Faecal incontinence
Sexual function Physical ability to have sexual intercourse
Sensation Perineal sensation
Sensation in genitals
Non-autonomic function Power Leg muscle strength
Pain Pain due to abnormal sensation or non-painful stimulus
Adverse Events Complications (including death)
Quality of life Global quality of life
Occupational role functioning
Social functioning
Ability to do daily activities
Mobility and walking
Low Mood and depression
https://doi.org/10.1371/journal.pone.0225907.t006
Cauda Equina Syndrome Core Outcome Set
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Discussion
This is the first study in the literature that has determined the Core Outcomes Set (COS) for
CES. It was registered on the COMET database and a transparent process has been used
involving an international Delphi survey and consensus meeting to decide the COS. Each out-
come included has been scored and agreed as critical by at least 70% of patients and 70% of
HCPs. This COS is recommended for use in any research study investigating CES outcomes as
they have been verified as important by key stakeholders. This will allow evidence synthesis in
CES.
It is noted that the numbers recruited in a Delphi survey can potentially be small if the con-
dition is rare[19]. A review of COS studies from the COMET database revealed that 22% had
recruited patients from 5 or more countries [22]. Inclusion of patients from multiple countries
is deemed more difficult than HCPs [19]. The CESCOS study recruited 172 participants for
both rounds and involved patients from 8 countries and HCPs from 12 countries. Participants
from the UK made up 55% and 45% were international of who most were patients. CES is a
rare condition so this was deemed to be a satisfactory response.
For the CESCOS Delphi, HCPs (82%) had a better response rate compared to the patients
(55%) in round 2. This may be a reflection that most HCPs were recruited from professional
Fig 1. Overview of core outcome set development and the final Cauda Equina Syndrome core outcome set.
https://doi.org/10.1371/journal.pone.0225907.g001
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organisations and patients were recruited openly from social media[21]. The importance of
completing both rounds of the Delphi may not have been emphasised enough through social
media. However, there was no attrition bias detected in the results of the CESCOS study.
Most HCPs taking part in the Delphi were of a surgical background and 63% had 10 years
or more experience after board certification as a consultant/ attending or the equivalent. This
is reflective of current CES management and research as it is managed as an acute condition
requiring emergency intervention in most cases[5, 6, 23]. Fifty percent patients were in the age
group of 30 to 49 and 52% of patients were not in employment or retired. This reflects that
CES adversely affects a working age population. Eighty-nine percent of patients had an opera-
tion for CES and this is consistent with the main aetiology for CES being a compressive pathol-
ogy which requires surgical decompression[4, 5]. As mentioned in the results, over half of the
HCPs attending the consensus meeting were involved in acute management and the rest
involved in longer term care and rehabilitation of CES patients, which would be reflective of a
group of HCPs that manage CES patients in the short and long term from diagnosis. There
was an equal spread of patients in the years since CES diagnosis, which would have also facili-
tated prioritisation of short and long term outcomes.
In Round 1, a higher proportion of HCPs scored autonomic related outcomes (urinary
retention, incontinence of urine, faecal incontinence and physical ability to have sexual inter-
course) as critically important compared to patients. Outcomes scored higher by patients in
Round 1 included genital sensation and life impact outcomes such as global quality of life, abil-
ity to do daily activities and mobility and walking. This agrees with the literature where HCPs
prioritise clinical outcomes compared to those related to life impact, which patients find
important. This was also reflected at an earlier stage when the verbatim outcome terms, which
were mentioned in the qualitative interviews and not in the SLR were mainly related to life
impact. There is evidence which suggests that patients tend to rate many or all outcome
domains as important in prioritisation exercises so HCP views would dominate as the outcome
domains they do not deem important will not be included in the final COS [24]. This was
observed for ten outcomes in the CES Delphi survey where�70% of patients voted them criti-
cal but HCPs had not therefore excluding them from the core outcome set at this stage
(Table 4). These outcomes were sensation of bladder fullness, anal tone, foot drop, low back
pain, leg pain, difficulty with body posture, anxiety, isolation, low mood and depression and
hospital resources. The outcome of anal tone, which has been measured in CES research stud-
ies[9, 25] is used as a proxy for faecal incontinence. However, anal tone was not voted into the
COS but faecal incontinence was, which highlights the importance of not just measuring what
clinicians believe is important.
Multiple group feedback between rounds has been shown to improve consensus between
stakeholder groups[26]. The CESCOS used this feedback method and found most HCPs
(58.4%) and some patients (27.6%) made score changes based on the feedback from the stake-
holder groups. This led to consensus on 13 outcomes to be included and 6 to be excluded at
the end of the Delphi survey. No participation bias was seen with the participants who
attended the consensus meeting.
A prospective study of long term outcomes after surgery for 46 CES patients had a mean
follow up of 43 months[27]. Validated questionnaires and unvalidated semi structured inter-
views were used to assess long term outcomes of bladder, bowel, sexual and physical function.
Not all the outcomes in the CESCOS have been measured. For example, perineal sensation,
sensation in genitals, leg muscle strength, pain due to abnormal sensation or non-painful stim-
ulus and complications from the operation, were not measured. For the outcomes that were
measured, there has not been a transparent consensus process[28] regarding the choice of
these outcome measurement instruments. In Table 5 of a systematic literature review[9], it was
Cauda Equina Syndrome Core Outcome Set
PLOS ONE | https://doi.org/10.1371/journal.pone.0225907 January 10, 2020 11 / 15
shown that between studies, there is a lack of uniformity in the assessments used for the out-
comes in CES, which makes it difficult to synthesise the results for meaningful analysis. The
CESCOS highlights the outcomes for which this process must be undertaken in a transparent
and methodologically sound manner.
There is little research into the uptake of core outcome sets in comparison to randomised
trials and systematic reviews as there are a relatively smaller number of them[19]. A review of
the rheumatoid arthritis COS established in 1994 showed that 81% of trials between 2002 and
2016 were reporting it[29]. Implementation is an important aspect to help promote uptake
and to aid this the CESCOS is registered on the COMET database, is published and will be pre-
sented at meetings and relevant HCP, patient and research funding bodies will be informed.
In the qualitative interviews, Delphi survey and consensus meeting for the CESCOS study,
patients were keen and willing to be involved. This may be a reflection that it is a rare syn-
drome so any attention or further research for the condition is actively engaged and welcomed
by them suggesting the burden of data collection is not an issue with this patient group. A
study reviewing the long-term outcomes after spinal surgery for CES showed that there was a
real need for HCPs to spend sufficient time discussing the difficult issues and delivering prog-
nostic information to patients regarding their outcomes[27]. This highlights the importance of
recording and reporting the CESCOS outcomes for future research studies. Currently, a multi-
centre prospective observational cohort study in CES is using the CESCOS[30] for its follow
up data collection. The pragmatic difficulties of data measurement will be explored here. The
COS should be reviewed in the future to see if any outcomes need to be added or subtracted
[19]. The aim is to do this in five years to analyse uptake in CES research studies.
Strengths and limitations
A varied sample was obtained for the qualitative interviews using a sampling frame, which
identified outcomes important to patients. The Delphi survey recruited participants from 14
countries and the consensus meeting recruited participants from 8 countries, which is signifi-
cant considering CES is a rare condition. The consensus process successfully involved both
patient and HCPs in the prioritisation of outcomes and agreement over the COS.
The study was only conducted in the English language due to time and budget resource lim-
itation. During the Delphi survey, details of how patients presented with CES were not collated
as it would not have been possible to verify these details with the respective medical notes
within the time limitations of the study.
Conclusion
We have determined 16 outcomes that are critical to key stakeholders (Table 6). In the medical
literature, there is a focus on the bladder dysfunction and clinical sequelae of CES [9]. There is
little emphasis on outcomes related to life impact. This COS has highlighted the importance of
all these outcomes to be assessed as the “minimum standard.” To ensure consistency in mea-
surement and reporting of these outcomes the next stage will involve gaining consensus
around standardised definitions and recommended measurement instruments for each out-
come in the COS following the COSMIN-COMET guidelines [28].
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